<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Daily Stocks News &#187; SHFL</title>
	<atom:link href="http://news.dailystocks.com/tag/shfl/feed/" rel="self" type="application/rss+xml" />
	<link>http://news.dailystocks.com</link>
	<description>Stocks with Insider Buying, Stock Search Engine, Glossary, Education, Reviews</description>
	<lastBuildDate>Mon, 21 Jan 2019 17:42:26 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>Major Gainers and Losers on September 11th; SNSS, UNFI, RFMD, SHFL, NAVB, AMD, PANW</title>
		<link>http://news.dailystocks.com/1463/major-gainers-and-losers-on-september-11th-snss-unfi-rfmd-shfl-navb-amd-panw/</link>
		<comments>http://news.dailystocks.com/1463/major-gainers-and-losers-on-september-11th-snss-unfi-rfmd-shfl-navb-amd-panw/#comments</comments>
		<pubDate>Tue, 11 Sep 2012 20:55:25 +0000</pubDate>
		<dc:creator>Warren Paige</dc:creator>
				<category><![CDATA[Large Cap Growth Stocks]]></category>
		<category><![CDATA[AMD]]></category>
		<category><![CDATA[NAVB]]></category>
		<category><![CDATA[PANW]]></category>
		<category><![CDATA[RFMD]]></category>
		<category><![CDATA[SHFL]]></category>
		<category><![CDATA[SNSS]]></category>
		<category><![CDATA[UNFI]]></category>

		<guid isPermaLink="false">http://news.dailystocks.com/?p=1463</guid>
		<description><![CDATA[<p>Shares of Sunesis Pharmaceuticals Inc. (NASDAQ: SNSS), a biopharmaceutical company engaged in the development and commercialization of oncology therapeutics for the treatment of solid and hematologic cancers, surged in trading today after the company announced that it will implement a one-time, 225-patient sample size increase in its Phase 3 VALOR trial.</p> <p></p> <p>SNSS shares rose [...]]]></description>
		<wfw:commentRss>http://news.dailystocks.com/1463/major-gainers-and-losers-on-september-11th-snss-unfi-rfmd-shfl-navb-amd-panw/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
